Zachary Shriver

7.6k total citations · 1 hit paper
91 papers, 4.2k citations indexed

About

Zachary Shriver is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Zachary Shriver has authored 91 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 50 papers in Cell Biology and 19 papers in Organic Chemistry. Recurrent topics in Zachary Shriver's work include Proteoglycans and glycosaminoglycans research (50 papers), Glycosylation and Glycoproteins Research (35 papers) and Influenza Virus Research Studies (17 papers). Zachary Shriver is often cited by papers focused on Proteoglycans and glycosaminoglycans research (50 papers), Glycosylation and Glycoproteins Research (35 papers) and Influenza Virus Research Studies (17 papers). Zachary Shriver collaborates with scholars based in United States, Singapore and United Kingdom. Zachary Shriver's co-authors include Ram Sasisekharan, Ganesh Venkataraman, Rahul Raman, Dongfang Liu, Karthik Viswanathan, S. Raguram, Ishan Capila, Robert J. Linhardt, K. Biemann and Yiwei Qi and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Zachary Shriver

91 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of heparan-sulphate glycosaminoglycans in cancer

2002 535 citations Ram Sasisekharan, Zachary Shriver et al. profile →

Peers

Countries citing papers authored by Zachary Shriver

Since Specialization

Citations

This map shows the geographic impact of Zachary Shriver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachary Shriver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachary Shriver more than expected).

Fields of papers citing papers by Zachary Shriver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachary Shriver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachary Shriver. The network helps show where Zachary Shriver may publish in the future.

Co-authorship network of co-authors of Zachary Shriver

This figure shows the co-authorship network connecting the top 25 collaborators of Zachary Shriver. A scholar is included among the top collaborators of Zachary Shriver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachary Shriver. Zachary Shriver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections 2023 ·PLoS Pathogens ·Kenneth D. Johnson, James C. Delaney, Thomas Guillard, Fany Reffuveille, Jennifer Varin, Kai Li, Andrew M. Wollacott, Eric Frapy, Surin K. Mong, Hamid Tissire, Karthik Viswanathan, Fayçal Touti, Gregory J. Babcock, Zachary Shriver, Bradley L. Pentelute, Obadiah J. Plante, David Skurnik	17
2	A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy 2019 ·Kidney International ·James R. Myette, Toshiki Kano, Hitoshi Suzuki, Susan Sloan, Kristy J. Szretter, Boopathy Ramakrishnan, Hedy Adari, (unknown), (unknown), Zachary Shriver, Andrew M. Wollacott, Yusuke Suzuki, Brian J.G. Pereira	62
3	Extending human IgG half-life using structure-guided design 2018 ·mAbs ·(unknown), Boopathy Ramakrishnan, Kristin Narayan, Andrew M. Wollacott, Gregory J. Babcock, Zachary Shriver, Karthik Viswanathan	76
4	Antibody–Bactericidal Macrocyclic Peptide Conjugates To Target Gram‐Negative Bacteria 2018 ·ChemBioChem ·Fayçal Touti, Guillaume Lautrette, Kenneth D. Johnson, James C. Delaney, Andrew M. Wollacott, Hamid Tissire, Karthik Viswanathan, Zachary Shriver, Surin K. Mong, Alexander J. Mijalis, Obadiah J. Plante, Bradley L. Pentelute	27
5	A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins 2018 ·Nature Chemistry ·Daniel T. Cohen, Chi Zhang, Colin M. Fadzen, Alexander J. Mijalis, Liana Hie, Kenneth D. Johnson, Zachary Shriver, Obadiah J. Plante, Scott J. Miller, Stephen L. Buchwald, Bradley L. Pentelute	81
6	Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates 2017 ·Antiviral Research ·Eugenia Z. Ong, (unknown), Hwee Cheng Tan, Luke N. Robinson, Kirk J. Rowley, Alexander Viloria Winnett, Sven N. Hobbie, Zachary Shriver, Gregory J. Babcock, Eng Eong Ooi	21
7	Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses 2015 ·Antiviral Research ·Gabriel L. Hendricks, (unknown), (unknown), Natasha Qaisar, James C. Delaney, Karthik Viswanathan, (unknown), James C. Comolli, Zachary Shriver, David M. Knipe, Evelyn A. Kurt‐Jones, Deborah Kuchnir Fygenson, José Trevejo, Jennifer Wang, Robert W. Finberg	29
8	Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus 2014 ·DSpace@MIT (Massachusetts Institute of Technology) ·Rahul Raman, Kannan Tharakaraman, Akila Jayaraman, Ram Sasisekharan, Zachary Shriver, V. Sasisekharan	1
9	Heparin and Heparan Sulfate: Analyzing Structure and Microheterogeneity [chapter] 2012 ·DSpace@MIT (Massachusetts Institute of Technology) ·Zachary Shriver, Ishan Capila, Ganesh Venkataraman, Ram Sasisekharan	1
10	Querying quantitative logic models (Q2LM) to study intracellular signaling networks and cell-cytokine interactions 2011 ·DSpace@MIT (Massachusetts Institute of Technology) ·Melody K. Morris, Zachary Shriver, Ram Sasisekharan, Douglas A. Lauffenburger	1
11	Heparin and Heparan Sulfate: Analyzing Structure and Microheterogeneity 2011 ·Handbook of experimental pharmacology ·Zachary Shriver, Ishan Capila, Ganesh Venkataraman, Ram Sasisekharan	170
12	Querying quantitative logic models (Q2LM) to study intracellular signaling networks and cell‐cytokine interactions 2011 ·Biotechnology Journal ·Melody K. Morris, Zachary Shriver, Ram Sasisekharan, Douglas A. Lauffenburger	6
13	Heparin/Heparan Sulfate N-Sulfamidase from Flavobacterium heparinum 2009 ·Journal of Biological Chemistry ·James R. Myette, Venkataramanan Soundararajan, (unknown), Zachary Shriver, Rahul Raman, Ram Sasisekharan	19
14	Context-Specific Target Definition in Influenza A Virus Hemagglutinin-Glycan Receptor Interactions 2009 ·Chemistry & Biology ·Zachary Shriver, Rahul Raman, Karthik Viswanathan, Ram Sasisekharan	22
15	HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor Growth in Vivo 2005 ·Journal of Biological Chemistry ·Yuemeng Dai, Yang Yang, Veronica MacLeod, Xinping Yue, Alan C. Rapraeger, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Ralph D. Sanderson	122
16	The Heparin/Heparan Sulfate 2-O-Sulfatase from Flavobacterium heparinum 2003 ·Journal of Biological Chemistry ·James R. Myette, Zachary Shriver, (unknown), Maitland W. McLEAN, Ganesh Venkataraman, Ram Sasisekharan	36
17	Direct isolation and sequencing of specific protein-binding glycosaminoglycans 2001 ·Nature Medicine ·(unknown), Ganesh Venkataraman, Zachary Shriver, Ram Sasisekharan	50
18	Probing Fibroblast Growth Factor Dimerization and Role of Heparin-like Glycosaminoglycans in Modulating Dimerization and Signaling 2001 ·Journal of Biological Chemistry ·(unknown), Ganesh Venkataraman, Zachary Shriver, Rahul Raman, Dongfang Liu, Yiwei Qi, Lyuba Varticovski, Ram Sasisekharan	37
19	6-O-Sulfotransferase-1 Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway 2001 ·Journal of Biological Chemistry ·Lijuan Zhang, David Beeler, Roger Lawrence, Miroslaw Lech, Jian Liu, (unknown), Zachary Shriver, Ram Sasisekharan, Robert Rosenberg	73
20	Simultaneous structure—activity determination of disulfiram photolysis products by on-line continuous-flow liquid secondary ion mass spectrometry and enzyme inhibition assay 1995 ·Journal of Chromatography A ·Linda M. Benson, Karen A. Veverka, Dennis C. Mays, Albert N. Nelson, Zachary Shriver, James J. Lipsky, Stephen Naylor	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact